Signature biomarker states and mortality among hospitalized SARS-CoV-2-infected patients.

Selvaggi, Caitlin; Harrison, Linda J; Kim, Eunyoung; Reilly, Muredach P; Foulkes, Andrea S

Selvaggi, Caitlin; Harrison, Linda J; Kim, Eunyoung; Reilly, Muredach P; Foulkes, Andrea S.

Selvaggi C; Biostatistics Center, Massachusetts General Hospital, 50 Staniford Street, Boston, MA, 02114, USA.
Harrison LJ; Biostatistics Center, Massachusetts General Hospital, 50 Staniford Street, Boston, MA, 02114, USA.
Kim E; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Reilly MP; Division of Cardiology, Columbia University, New York, NY, USA.
Foulkes AS; Division of Cardiology, Columbia University, New York, NY, USA.

J Nephrol ; 35(3): 765-767, 2022 04.

Article in English | MEDLINE | ID: covidwho-1607789

Subject(s)

COVID-19; SARS-CoV-2; Biomarkers; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Nephrol Journal subject: Nephrology Year: 2022 Document Type: Article Affiliation country: S40620-021-01239-z

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google